QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 153 filers reported holding QIAGEN NV in Q2 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,056,000 | -2.5% | 216,129 | -4.5% | 0.01% | 0.0% |
| Q3 2016 | $6,212,000 | +33.8% | 226,375 | +6.3% | 0.01% | +25.0% |
| Q2 2016 | $4,644,000 | -5.6% | 212,939 | -3.3% | 0.00% | 0.0% |
| Q1 2016 | $4,920,000 | -57.1% | 220,255 | -46.9% | 0.00% | -60.0% |
| Q4 2015 | $11,469,000 | +74.6% | 414,786 | +62.9% | 0.01% | +66.7% |
| Q3 2015 | $6,569,000 | +19.9% | 254,629 | +15.2% | 0.01% | +20.0% |
| Q2 2015 | $5,481,000 | -45.2% | 221,107 | -44.4% | 0.01% | -37.5% |
| Q1 2015 | $10,006,000 | +154.5% | 397,799 | +137.4% | 0.01% | +166.7% |
| Q4 2014 | $3,932,000 | -14.8% | 167,584 | -17.3% | 0.00% | -25.0% |
| Q3 2014 | $4,613,000 | -6.8% | 202,584 | +0.0% | 0.00% | 0.0% |
| Q2 2014 | $4,951,000 | +24.1% | 202,484 | +7.0% | 0.00% | +33.3% |
| Q1 2014 | $3,990,000 | -40.6% | 189,190 | -32.9% | 0.00% | -50.0% |
| Q4 2013 | $6,714,000 | +7.7% | 281,992 | -3.2% | 0.01% | 0.0% |
| Q3 2013 | $6,234,000 | +7.8% | 291,322 | +0.3% | 0.01% | 0.0% |
| Q2 2013 | $5,782,000 | – | 290,391 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |